Cargando…
Alternative diagnoses and demographics associated with a raised quantitative faecal immunochemical test in symptomatic patients
BACKGROUND: The faecal immunochemical test (FIT) has proven utility for colorectal cancer detection in symptomatic patients. However, most patients with a raised faecal haemoglobin (f-Hb) do not have colorectal cancer. We investigated alternative diagnoses and demographics associated with a raised f...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280700/ https://www.ncbi.nlm.nih.gov/pubmed/35044264 http://dx.doi.org/10.1177/00045632221076771 |
_version_ | 1784746707087523840 |
---|---|
author | Johnstone, Mark S Miller, Gillian Pang, Grace Burton, Paul Kourounis, Georgios Winter, Jack Crighton, Emilia Mansouri, David Witherspoon, Paul Smith, Karen McSorley, Stephen T |
author_facet | Johnstone, Mark S Miller, Gillian Pang, Grace Burton, Paul Kourounis, Georgios Winter, Jack Crighton, Emilia Mansouri, David Witherspoon, Paul Smith, Karen McSorley, Stephen T |
author_sort | Johnstone, Mark S |
collection | PubMed |
description | BACKGROUND: The faecal immunochemical test (FIT) has proven utility for colorectal cancer detection in symptomatic patients. However, most patients with a raised faecal haemoglobin (f-Hb) do not have colorectal cancer. We investigated alternative diagnoses and demographics associated with a raised f-Hb in symptomatic patients. METHODS: A retrospective, observational study was performed of patients with FIT submitted between August 2018 to January 2019 in NHS Greater Glasgow and Clyde followed by colonoscopy. Colonoscopy/pathology reports were searched for alternative diagnoses. Covariables were compared using the χ( 2 ) test. Multivariate binary logistic regression identified independent predictors of a raised f-Hb. RESULTS: 1272 patients were included. In addition to colorectal cancer (odds ratio (OR), 9.27 (95% confidence interval (CI): 3.61–23.83; p < 0.001)), older age (OR, 1.52 (95% CI: 1.00–2.32; p = 0.05)), deprivation (OR, 1.54 (95% CI: 1.21–1.94; p < 0.001)), oral anticoagulants (OR, 1.78 (95% CI: 1.01–3.15; p = 0.046)), rectal bleeding (OR, 1.47 (95% CI: 1.15–1.88; p = 0.002)), advanced adenoma (OR, 7.52 (95% CI: 3.90–14.49; p < 0.001)), non-advanced polyps (OR, 1.78 (95% CI: 1.33–2.38; p < 0.001)) and inflammatory bowel disease (IBD) (OR, 4.19 (95% CI: 2.17–8.07; p < 0.001)) independently predicted raised f-Hb. Deprivation (Scottish Index of Multiple Deprivation (SIMD) 1-2: OR, 2.13 (95% CI: 1.38–3.29; p = 0.001)) independently predicted a raised f-Hb in patients with no pathology found at colonoscopy. CONCLUSIONS: An elevated f-Hb is independently associated with older age, deprivation, anticoagulants, rectal bleeding, advanced adenoma, non-advanced polyps and IBD in symptomatic patients. Deprivation is associated with a raised f-Hb in the absence of pathology. This must be considered when utilising FIT in symptomatic patients. |
format | Online Article Text |
id | pubmed-9280700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-92807002022-07-15 Alternative diagnoses and demographics associated with a raised quantitative faecal immunochemical test in symptomatic patients Johnstone, Mark S Miller, Gillian Pang, Grace Burton, Paul Kourounis, Georgios Winter, Jack Crighton, Emilia Mansouri, David Witherspoon, Paul Smith, Karen McSorley, Stephen T Ann Clin Biochem Research Articles BACKGROUND: The faecal immunochemical test (FIT) has proven utility for colorectal cancer detection in symptomatic patients. However, most patients with a raised faecal haemoglobin (f-Hb) do not have colorectal cancer. We investigated alternative diagnoses and demographics associated with a raised f-Hb in symptomatic patients. METHODS: A retrospective, observational study was performed of patients with FIT submitted between August 2018 to January 2019 in NHS Greater Glasgow and Clyde followed by colonoscopy. Colonoscopy/pathology reports were searched for alternative diagnoses. Covariables were compared using the χ( 2 ) test. Multivariate binary logistic regression identified independent predictors of a raised f-Hb. RESULTS: 1272 patients were included. In addition to colorectal cancer (odds ratio (OR), 9.27 (95% confidence interval (CI): 3.61–23.83; p < 0.001)), older age (OR, 1.52 (95% CI: 1.00–2.32; p = 0.05)), deprivation (OR, 1.54 (95% CI: 1.21–1.94; p < 0.001)), oral anticoagulants (OR, 1.78 (95% CI: 1.01–3.15; p = 0.046)), rectal bleeding (OR, 1.47 (95% CI: 1.15–1.88; p = 0.002)), advanced adenoma (OR, 7.52 (95% CI: 3.90–14.49; p < 0.001)), non-advanced polyps (OR, 1.78 (95% CI: 1.33–2.38; p < 0.001)) and inflammatory bowel disease (IBD) (OR, 4.19 (95% CI: 2.17–8.07; p < 0.001)) independently predicted raised f-Hb. Deprivation (Scottish Index of Multiple Deprivation (SIMD) 1-2: OR, 2.13 (95% CI: 1.38–3.29; p = 0.001)) independently predicted a raised f-Hb in patients with no pathology found at colonoscopy. CONCLUSIONS: An elevated f-Hb is independently associated with older age, deprivation, anticoagulants, rectal bleeding, advanced adenoma, non-advanced polyps and IBD in symptomatic patients. Deprivation is associated with a raised f-Hb in the absence of pathology. This must be considered when utilising FIT in symptomatic patients. SAGE Publications 2022-03-03 2022-07 /pmc/articles/PMC9280700/ /pubmed/35044264 http://dx.doi.org/10.1177/00045632221076771 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research Articles Johnstone, Mark S Miller, Gillian Pang, Grace Burton, Paul Kourounis, Georgios Winter, Jack Crighton, Emilia Mansouri, David Witherspoon, Paul Smith, Karen McSorley, Stephen T Alternative diagnoses and demographics associated with a raised quantitative faecal immunochemical test in symptomatic patients |
title | Alternative diagnoses and demographics associated with a raised
quantitative faecal immunochemical test in symptomatic patients |
title_full | Alternative diagnoses and demographics associated with a raised
quantitative faecal immunochemical test in symptomatic patients |
title_fullStr | Alternative diagnoses and demographics associated with a raised
quantitative faecal immunochemical test in symptomatic patients |
title_full_unstemmed | Alternative diagnoses and demographics associated with a raised
quantitative faecal immunochemical test in symptomatic patients |
title_short | Alternative diagnoses and demographics associated with a raised
quantitative faecal immunochemical test in symptomatic patients |
title_sort | alternative diagnoses and demographics associated with a raised
quantitative faecal immunochemical test in symptomatic patients |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280700/ https://www.ncbi.nlm.nih.gov/pubmed/35044264 http://dx.doi.org/10.1177/00045632221076771 |
work_keys_str_mv | AT johnstonemarks alternativediagnosesanddemographicsassociatedwitharaisedquantitativefaecalimmunochemicaltestinsymptomaticpatients AT millergillian alternativediagnosesanddemographicsassociatedwitharaisedquantitativefaecalimmunochemicaltestinsymptomaticpatients AT panggrace alternativediagnosesanddemographicsassociatedwitharaisedquantitativefaecalimmunochemicaltestinsymptomaticpatients AT burtonpaul alternativediagnosesanddemographicsassociatedwitharaisedquantitativefaecalimmunochemicaltestinsymptomaticpatients AT kourounisgeorgios alternativediagnosesanddemographicsassociatedwitharaisedquantitativefaecalimmunochemicaltestinsymptomaticpatients AT winterjack alternativediagnosesanddemographicsassociatedwitharaisedquantitativefaecalimmunochemicaltestinsymptomaticpatients AT crightonemilia alternativediagnosesanddemographicsassociatedwitharaisedquantitativefaecalimmunochemicaltestinsymptomaticpatients AT mansouridavid alternativediagnosesanddemographicsassociatedwitharaisedquantitativefaecalimmunochemicaltestinsymptomaticpatients AT witherspoonpaul alternativediagnosesanddemographicsassociatedwitharaisedquantitativefaecalimmunochemicaltestinsymptomaticpatients AT smithkaren alternativediagnosesanddemographicsassociatedwitharaisedquantitativefaecalimmunochemicaltestinsymptomaticpatients AT mcsorleystephent alternativediagnosesanddemographicsassociatedwitharaisedquantitativefaecalimmunochemicaltestinsymptomaticpatients |